Wörns MA - Search Results

1

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.

Castven D, Czauderna C, Becker D, Pereira S, Schmitt J, Weinmann A, Shah V, Hajduk J, Keggenhoff F, Binder H, Keck T, Heilmann-Heimbach S, Wörns MA, Thorgeirsson SS, Breuhahn K, Galle PR, Marquardt JU. Castven D, et al. Among authors: worns ma. Hepatol Commun. 2022 May;6(5):1140-1156. doi: 10.1002/hep4.1869. Epub 2021 Nov 24. Hepatol Commun. 2022. PMID: 34817932 Free PMC article.

2

Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.

Wörns MA, Lohse AW, Neurath MF, Croxford A, Otto G, Kreft A, Galle PR, Kanzler S. Wörns MA, et al. Am J Gastroenterol. 2006 Aug;101(8):1931-7. doi: 10.1111/j.1572-0241.2006.00624.x. Epub 2006 Jun 22. Am J Gastroenterol. 2006. PMID: 16790037

3

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T. Wörns MA, et al. Am J Gastroenterol. 2008 Jan;103(1):138-46. doi: 10.1111/j.1572-0241.2007.01609.x. Epub 2007 Oct 26. Am J Gastroenterol. 2008. PMID: 17970833

4

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR. Wörns MA, et al. J Clin Gastroenterol. 2009 May-Jun;43(5):489-95. doi: 10.1097/MCG.0b013e31818ddfc6. J Clin Gastroenterol. 2009. PMID: 19247201

5

A systems biology perspective on cholangiocellular carcinoma development: focus on MAPK-signaling and the extracellular environment.

Wang C, Maass T, Krupp M, Thieringer F, Strand S, Wörns MA, Barreiros AP, Galle PR, Teufel A. Wang C, et al. Among authors: worns ma. J Hepatol. 2009 Jun;50(6):1122-31. doi: 10.1016/j.jhep.2009.01.024. Epub 2009 Mar 31. J Hepatol. 2009. PMID: 19395114

6

Systemic therapies in hepatocellular carcinoma.

Wörns MA, Weinmann A, Schuchmann M, Galle PR. Wörns MA, et al. Dig Dis. 2009;27(2):175-88. doi: 10.1159/000218351. Epub 2009 Jun 22. Dig Dis. 2009. PMID: 19546557 Review.

7

Concurrent autoimmune diseases in patients with autoimmune hepatitis.

Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, Lohse AW, Galle PR, Kanzler S. Teufel A, et al. J Clin Gastroenterol. 2010 Mar;44(3):208-13. doi: 10.1097/MCG.0b013e3181c74e0d. J Clin Gastroenterol. 2010. PMID: 20087196

8

Novel inhibitors in development for hepatocellular carcinoma.

Wörns MA, Galle PR. Wörns MA, et al. Expert Opin Investig Drugs. 2010 May;19(5):615-29. doi: 10.1517/13543781003767418. Expert Opin Investig Drugs. 2010. PMID: 20374038 Review.

9

Future perspectives in hepatocellular carcinoma.

Wörns MA, Galle PR. Wörns MA, et al. Dig Liver Dis. 2010 Jul;42 Suppl 3:S302-9. doi: 10.1016/S1590-8658(10)60521-X. Dig Liver Dis. 2010. PMID: 20547319 Review.

10

Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatment.

Wörns MA, Schuchmann M, Düber C, Otto G, Galle PR, Weinmann A. Wörns MA, et al. Oncology. 2010;79(1-2):85-92. doi: 10.1159/000320363. Epub 2010 Nov 12. Oncology. 2010. PMID: 21071995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters